Pharmacists’ considerations on non-medical switching at the hospital: a systematic review of the economic outcomes of cost-saving therapeutic drug classes
68% of studies reported reduced costs with no significant changes in health outcomes (HO); 8% reported deterioration in HO and/or increased costs. More data on switching strategies targeting medicines requiring extensive clinical assessment (e.g. antineoplastics) are needed.
Source:
European Journal of Hospital Pharmacy